Source: Annual Congress 2003 - Markers, mediators and mechanisms of human lung injury
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
E. Pace, M. Profita, M. R. Melis, A. Bonanno, A. M. Vignola, C. H. Mody, A. Tipa, M. Ferraro, M. Spatafora, G. Bonsignore, M. Gjomarkaj (Palermo, Italy; Calgary, Canada). Mesothelioma cells counteract talc toxicity by prostaglandin E2 (PGE2). Eur Respir J 2003; 22: Suppl. 45, 625

Member's Comments

No comment yet.

Related content which might interest you: NF-κB-dependent cytokine production is abolished by cyclopentenone prostaglandins in lung epithelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 354s Year: 2001 Bronchoconstriction induced by prostaglandin D2 (PGD2) in guinea pig lung is enhanced by selective COX-2 inhibition Source: Eur Respir J 2006; 28: Suppl. 50, 759s Year: 2006 Anti-inflammatory effect of Lipoxin A4 (LXA4) on human bronchial epithelial cells Source: Eur Respir J 2002; 20: Suppl. 38, 619s Year: 2002 Downregulation of prostaglandin E2 in bronchial fibroblasts of asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Fe2O3 particle-induced prostaglandin E2 (PGE2) synthesis in alveolar macrophages (AM) determines particulate inflammatory potential Source: Annual Congress 2005 - Traffic, particles and health Year: 2005 Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing Source: Eur Respir J 2006; 27: 944-950 Year: 2006 Prostaglandin D2 inhibits fibroblast migration Source: Eur Respir J 2002; 19: 684-689 Year: 2002 Increased COX-1 and COX-2 mRNA expression and prostaglandin E2 production by dendritic cells from patients with asthma Source: Annual Congress 2003 - Intracellular signalling and regulation of cytokine production Year: 2003 Increased leukotriene and lower prostaglandin E2 concentrations in induced sputum of patients with eosinophilic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005 Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages Source: Eur Respir J 2007; 29: 986-994 Year: 2007 Prostaglandin E2 suppresses the function of human group 2 innate lymphoid cells Source: International Congress 2018 – Roles of innate lymphoid cells in asthma Year: 2018 Fevipiprant inhibits eosinophil activation induced by multiple metabolites of prostaglandin D2 Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Prostaglandin D2 (PGD2) and tryptase release into blood after adenosine and methacholine challenges in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006 Liver-X-receptor agonists, but not dexamethasone, inhibit leukotriene production from human white blood cells pretreated with GM-CSF and activated with fMLP Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007 Regulation of cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogues Source: Eur Respir J 2009; 33: 405-410 Year: 2009 Effects on cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogs Source: Annual Congress 2009 - Translational models of lung disease Year: 2009 Involvement of eicosanoids and surfactant protein D in extrinsic allergic alveolitis Source: Eur Respir J 2005; 26: 1069-1073 Year: 2005 Evidence of mast cell activation and leukotriene release after mannitol inhalation Source: Eur Respir J 2003; 22: 491-496 Year: 2003 Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion Source: Eur Respir J 2001; 18: 15-22 Year: 2001